Karn Wijarnpreecha

Associate Clinical Professor

University of Arizona College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (8)

Brittany Dennis

Assistant Professor

The University of British Columbia

CANADA

View details

Fang Li

Assistant Professor

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Anna SF Lok

University of Michigan

UNITED STATES

View details

Nicola Coppola

ITALY

View details

Yu Jun Wong

National University of Singapore (NUS)

SINGAPORE

View details

Vincent Chen

Assistant Professor

University of Michigan Medical School

UNITED STATES

View details

Jakrapun Pupaibool

Associate Professor

University of Utah School of Medicine

UNITED STATES

View details

Donghee Kim

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karn Wijarnpreecha

Research Interests

Explore related searches

Contact this professor

Articles (20)

Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Authors' reply

Estimated pulse wave velocity in metabolic dysfunction‐associated steatotic liver disease and all‐cause/cause‐specific mortality

Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake

Contemporary Awareness of Nonalcoholic Fatty Liver Disease and Viral Hepatitis Based on the Stage

Editorial: Sounding the alarm—The rising global burden of adolescent and young adult alcohol‐related liver disease. Author's reply

Financial hardship and cost‐related nonadherence to medication in patients with liver disease in the United States

Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States

The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults

Clostridioides Difficile Infection in the Elderly: Trend Analysis from 2000 to 2019

THE TRENDS AND INCIDENCE OF ALCOHOL-ASSOCIATED HEPATITIS HOSPITALIZATIONS FROM 2016-2020 AND THE IMPACT OF THE COVID-19 PANDEMIC.

Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific Mortality among Adults in the United States

Global Epidemiology and Burden of Elderly-Onset Inflammatory Bowel Disease: A Decade in Review

Trends in aetiology‐based hospitalisation for cirrhosis before and during the COVID‐19 pandemic in the United States

Treatment Outcomes of Sofosbuvir/Velpatasvir/Voxilaprevir in Direct-Acting Antiviral-Experienced Hepatitis C Virus Patients: A Systematic Review and Meta-Analysis

Editorial: clinical outcomes in lean NAFLD – the devil is in the details. Authors' reply

Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality

Muscle strength in non‐alcoholic fatty liver disease and all‐cause and cause‐specific mortality

Watch out for the Saurkraut: Weissella confusa endocarditis in a liver transplant candidate

DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals

Collaborators (8)

Brittany Dennis

Fang Li

Anna SF Lok

Nicola Coppola

Yu Jun Wong

Vincent Chen

Jakrapun Pupaibool

Donghee Kim

Make your next move.